Products for Research Use Only

TrkA-IN-9

CAT: 0013-GTR19259435-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19259435-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TrkA-IN-9 (VMD-928) is an orally active and selective inhibitor of tropomyosin receptor kinase A (TrkA) . It disrupts downstream signaling pathways activated by nerve growth factor (NGF) binding to TrkA, thereby inhibiting cell proliferation and invasion, and promoting cancer cell death. TrkA-IN-9 shows potential for research in various cancers, including prostate cancer, thymic carcinoma, mesothelioma, head and neck squamous cell carcinoma, lung cancer, ovarian cancer, and hepatocellular carcinoma.
CAS Number
1802770-18-8
Field of Research
Signal Transduction
Smiles
O=C (O) C1=CC=C (C=C1) NC=2C=C (C (N) =C3C (=O) C=4C=CC=CC4C (=O) C23) N5CCN (CC5) C6CCCCC6
Molecular Formula
C31H32N4O4
Molecular Weight
524.61
Storage Conditions
-20°C
Notes
For research use only.